Update on Mechanisms of Ischemic Acute Kidney Injury
The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Acute renal failure (ARF), classically defined as an abrupt decrease in kidney function that leads to accumulation of nitrogenous wastes such as blood urea nitrogen and creatinine, is a common clinical problem with increasing incidence, serious consequences, unsatisfactory therapeutic options, and an enormous financial burden to society (1–5). ARF may be classified as prerenal (functional response of structurally normal kidneys to hypoperfusion), intrinsic renal (involving structural damage to the renal parenchyma), and postrenal (urinary tract obstruction). This review focuses on intrinsic ARF, which has emerged as the most common and serious subtype in hospitalized patients and can be associated pathologically with acute tubular necrosis (ATN). Consequently, it still is common clinical practice to use the terms intrinsic ARF and ATN interchangeably. Despite decades of pioneering basic research and important technical advances in clinical care, the prognosis for patients with intrinsic ARF remains poor, with a mortality rate of 40 to 80% in the intensive care setting. Two major problems have plagued the field and hindered progress. First, well over 20 definitions for ARF have been used in published studies, ranging from dialysis requirement to subtle increases in serum creatinine (6). In an attempt to standardize the definition and reflect the entire spectrum of the condition, the term acute kidney injury (AKI) has been proposed (4). AKI refers to a complex disorder that comprises multiple causative factors and occurs in a variety of settings with varied clinical manifestations that range from a minimal but sustained elevation in serum creatinine to anuric renal failure. Prerenal azotemia and other fully reversible causes of acute renal insufficiency are specifically excluded from the spectrum of AKI. An inherent shortcoming of this term is the continued reliance on serum creatinine measurements, and the definition of AKI undoubtedly will undergo enhancements as novel early biomarkers for the identification of ARF before the rise in serum creatinine come to light (7). This review avoids the term ATN and uses the expressions AKI and intrinsic ARF transposably. The second problem is an incomplete understanding of the cellular and molecular mechanisms that underlie AKI. This review updates the reader on current advances in basic and translational research that hold promise in human ischemic AKI. Classic concepts are mentioned briefly as founding principles but expanded on only if contemporary findings substantiate or refute them. The reader is referred to recent publications that address the mechanisms that underlie other causes of intrinsic AKI, such as sepsis (8) and nephrotoxins (9). However, from the clinical viewpoint, it is acknowledged that AKI is frequently multifactorial, with concomitant ischemic, nephrotoxic, and septic components and with overlapping pathogenetic mechanisms. Alterations in Morphology If function depends on form, then it follows that mechanisms that are invoked to elucidate kidney dysfunction in AKI also must explain the morphologic alterations. In this regard, the term ATN is a misnomer, because frank tubule cell necrosis is rarely encountered in human ARF. This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11). Prominent morphologic features of ischemic AKI in humans include effacement and loss of proximal tubule brush border, patchy loss of tubule cells, focal areas of proximal tubular dilation and distal tubular casts, and areas of cellular regeneration (12). Necrosis is inconspicuous and restricted to the highly susceptible outer medullary regions. The glomeruli are usually unimpressive, unless a primary glomerular disease had caused the ARF. This apparent disparity between the severe impairment of renal function and the relatively subtle histologic changes in AKI traditionally has been bothersome. More recently, however, reconciliation has been forthcoming from a consistent finding of apoptotic cell death in both distal and proximal tubules in both ischemic and nephrotoxic forms of human AKI (9,10). In addition, a great deal of attention has been directed toward the peritubular capillaries, which display a striking vascular congestion, endothelial damage, and leukocyte accumulation (13–15). The mechanisms that underlie these newly emphasized morphologic findings and their implications for the ensuing profound renal dysfunction are detailed herein. Alterations in Hemodynamics An intense and persistent renal vasoconstriction that reduces overall kidney blood flow to approximately 50% of normal has long been considered a hallmark of intrinsic ARF, prompting the previous designation of “vasomotor nephropathy” (1). As if to add insult to injury, the postischemic kidney also displays peculiar regional alterations in blood
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of this multifaceted protective action, NGAL has emerged as a prime therapeutic target in ischaemic AKI [379].”
In the citing paper
“The finding that NGAL was one of the most highly expressed proteins following ischaemia-reperfusion injury in kidney cells [372-374], and prognostic of kidney damage long before the more traditional marker creatinine was raised significantly, has led to considerable interest in this protein, especially as a marker of renal injury [375-389]”
Citations
Cites
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090740 · Cited by 3,408
Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M. M., Ma, Q., Kelly, C., Ruff, S. M., Zahedi, K., Shao, M., Bean, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74811-x · Cited by 2,394 · cited 1×
“protein is markedly upregulated in kidney tubules very early after ischemic AKI in animals (38) and humans (190) and is rapidly excreted in the urine, where it represents a novel, sensitive, early biomarker of ischemic AKI (38,191).”
Self-citationKidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., & Bonventre, J. V. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00433.x · Cited by 1,929 · cited 1×
“cal membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
BackgroundMishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088027.54400.c6 · Cited by 1,749
Self-citationIchimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L., & Sanicola, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4135 · Cited by 1,265 · cited 4×
“KIM-1 protein subsequently was demonstrated to be upregulated in postischemic animal and human kidney tubules, predominantly on the apical membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
MethodInfluentialAcute Renal Failure and Sepsis
Schrier, R. W., & Wang, W. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032401 · Cited by 1,260
Tögel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2005 · Cited by 1,178 · cited 1×
“Fourth, the mode of protection by exogenously administered MSC may be related not to transdifferentiation processes but rather to powerful anti-inflammatory and antiapoptotic mechanisms that are being uncovered (117,124,125).”
BackgroundROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Delayed graft function in kidney transplantation
Perico, N., Cattaneo, D., Sayegh, M. H., & Remuzzi, G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17406-0 · Cited by 972 · cited 1×
“This fact has once again been driven home by careful examination of protocol kidney biopsies that are obtained soon after deceased-donor transplantation (10), which represents a predictable model for ischemic AKI (11).”
BackgroundIschemic acute renal failure: An inflammatory disease?
Bonventre, J. V., & Zuk, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_2.x · Cited by 770
Recent Advances in the Pathophysiology of Ischemic Acute Renal Failure
Bonventre, J. V., & Weinberg, J. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079785.13922.f6 · Cited by 767 · cited 1×
“translational AKI research that has been made since this topic last was reviewed in JASN less than 3 yr ago (208) is chronicled”
Morigi, M., Imberti, B., Zoja, C., Corna, D., Tomasoni, S., Abbate, M., Rottoli, D., Angioletti, S., Benigni, A., Perico, N., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128974.07460.34 · Cited by 755
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Schrier, R. W., Wang, W., Poole, B., & Mitra, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22353 · Cited by 683 · cited 3×
“Possible mechanisms include (1) adhesion of platelets to the endothelium, with subsequent leukocyte adhesion, and (2) adhesion of platelets to neutrophils, with consequent aggregate formation and trapping in narrow peritubular capillaries (132).”
BackgroundVaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A., & Bonventre, J. V. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00291.2005 · Cited by 656
An Iron Delivery Pathway Mediated by a Lipocalin
Yang, J., Goetz, D., Li, J.-Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00710-4 · Cited by 651
Basile, D. P., Donohoe, D., Roethe, K., & Osborn, J. L. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.5.f887 · Cited by 619
Calvillo, L., Latini, R., Kajstura, J., Leri, A., Anversa, P., Ghezzi, P., Salio, M., Cerami, A., & Brines, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630444100 · Cited by 611 · cited 1×
“Similarly, erythropoietin, used extensively in humans for stimulating erythropoiesis, also has prominent antiapoptotic and antiinflammatory actions (179) and has been used successfully for functional amelioration of ischemic AKI in animals (65,77,180).”
BackgroundDedifferentiation and Proliferation of Surviving Epithelial Cells in Acute Renal Failure
Bonventre, J. V. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000067652.51441.21 · Cited by 593 · cited 1×
“Morphologically, repair is heralded by the appearance of dedifferentiated epithelial cells that express vimentin, a marker for multipotent mesenchymal cells (101).”
BackgroundDuffield, J. S., Park, K. M., Hsiao, L.-L., Kelley, V. R., Scadden, D. T., Ichimura, T., & Bonventre, J. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22593 · Cited by 571 · cited 1×
“First, the number of bone marrow–derived MSC that finally appear in the postischemic kidney is very small, and their detection has been fraught with technical false-positive results (116,117).”
BackgroundRenal-associated TLR2 mediates ischemia/reperfusion injury in the kidney
Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J. D., Kirschning, C. J., Akira, S., van der Poll, T., Weening, J. J., & Florquin, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22832 · Cited by 563 · cited 1×
“Toll-like receptor 2 (TLR2) may represent a major component of this proinflammatory response (70).”
BackgroundBrenner and Rector's the Kidney
Brenner, B. M. (2003) · Medical Entomology and Zoology · Cited by 561
Microvascular endothelial injury and dysfunction during ischemic acute renal failure
Sutton, T. A., Fisher, C. J., & Molitoris, B. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00631.x · Cited by 560
Bone marrow stem cells contribute to repair of the ischemically injured renal tubule
Kale, S., Karihaloo, A., Clark, P. R., Kashgarian, M., Krause, D. S., & Cantley, L. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17856 · Cited by 550
Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin
Mishra, J., Mori, K., Ma, Q., Kelly, C., Yang, J., Mitsnefes, M., Barasch, J., & Devarajan, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145013.44578.45 · Cited by 536 · cited 2×
“inhibition of apoptosis of tubule epithelial cells (40,41).”
BackgroundSelf-citationMishra, J., Mori, K., Ma, Q., Kelly, C., Barasch, J., & Devarajan, P. (2004) · American Journal of Nephrology · doi:10.1159/000078452 · Cited by 535
Self-citationThe renal papilla is a niche for adult kidney stem cells
Oliver, J. A., Maarouf, O., Cheema, F. H., Martens, T. P., & Al-Awqati, Q. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420921 · Cited by 534
Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure
Burne, M. J., Daniels, F., Ghandour, A. E., Mauiyyedi, S., Colvin, R. B., O’Donnell, M. P., & Rabb, H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12080 · Cited by 481
Differential gene expression following early renal ischemia/reperfusion
Supavekin, S., Zhang, W., Kucherlapati, R., Kaskel, F. J., Moore, L. C., & Devarajan, P. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00928.x · Cited by 465 · cited 2×
“the mRNA (56) and protein (55) levels, and inhibition of p53 by”
BackgroundSelf-citationPredominant role for C5b-9 in renal ischemia/reperfusion injury
Zhou, W., Farrar, C. A., Abe, K., Pratt, J. R., Marsh, J. E., Wang, Y., Stahl, G. L., & Sacks, S. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8621 · Cited by 465 · cited 1×
“(163,164), several recent observations have challenged this view”
BackgroundInflammatory cells in ischemic acute renal failure
Friedewald, J. J., & Rabb, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_3.x · Cited by 453 · cited 4×
“Although ablation of the ICAM-1 gene and pretreatment with ICAM-1 antibody rendered mice resistant to ischemic AKI, human trials with anti–ICAM-1 mAb administered after ischemia did not prevent AKI in cadaveric transplant recipients (14).”
BackgroundInfluentialPlasma cytokine levels predict mortality in patients with acute renal failure
Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., Paganini, E. P., Soroko, S., Freedman, S., Becker, K., Spratt, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00512.x · Cited by 444
Lin, F., Moran, A., & Igarashi, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23015 · Cited by 427 · cited 1×
“Second, the majority of these bone marrow–derived cells were detected in the interstitial compartment and not in nephron segments, raising concerns for accentuation of renal fibrosis after AKI (118,119).”
BackgroundThe dark side of C5a in sepsis
Ward, P. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1269 · Cited by 422
Lange, C., Tögel, F., Ittrich, H., Clayton, F., Nolte-Ernsting, C., Zander, A. R., & Westenfelder, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00573.x · Cited by 414
Lin, F., Cordes, K., Li, L., Hood, L., Couser, W. G., Shankland, S. J., & Igarashi, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000061595.28546.a0 · Cited by 412
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Endothelial injury and dysfunction: Role in the extension phase of acute renal failure
Molitoris, B. A., & Sutton, T. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_5.x · Cited by 366 · cited 1×
“To this paradigm, the addition of an “extension” phase after the initiation phase has been proposed, primarily to reflect previously underestimated amplification processes (15,205).”
BackgroundShedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration
Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M., & Bonventre, J. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200562200 · Cited by 355 · cited 1×
“cal membranes of proximal tubule epithelial cells, where it may play a role in renal regeneration (187,188).”
BackgroundKidney NGAL is a novel early marker of acute injury following transplantation
Mishra, J., Ma, Q., Kelly, C., Mitsnefes, M., Mori, K., Barasch, J., & Devarajan, P. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0055-0 · Cited by 354 · cited 1×
“protein is markedly upregulated in kidney tubules very early after ischemic AKI in animals (38) and humans (190) and is rapidly excreted in the urine, where it represents a novel, sensitive, early biomarker of ischemic AKI (38,191).”
BackgroundSelf-citationPathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice
Rabb, H., Daniels, F., O'Donnell, M., Haq, M., Saba, S. R., Keane, W., & Tang, W. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f525 · Cited by 352 · cited 1×
“Double CD4/CD8 knockout mice are protected from ischemic AKI (148), and adoptive transfer of wild-type T cells into the null mice abrogates this protective Figure 4.”
BackgroundCofilin phosphatases and regulation of actin dynamics
Huang, T. Y., DerMardirossian, C., & Bokoch, G. M. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.11.005 · Cited by 339
Acute Renal Failure Definitions and Classification: Time for Change?
Mehta, R. L., & Chertow, G. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079042.13465.1a · Cited by 338 · cited 1×
“First, well over 20 definitions for ARF have been used in published studies, ranging from dialysis requirement to subtle increases in serum creatinine (6).”
MethodDay, Y.-J., Huang, L., Ye, H., Linden, J., & Okusa, M. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00378.2004 · Cited by 331 · cited 1×
“tissue injury by macrophages seems additionally to require the coordinated action of T cells and neutrophils (144).”
BackgroundTHE ROLE OF THE COMPLEMENT SYSTEM IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., & Taylor, S. M. (2004) · Shock · doi:10.1097/00024382-200405000-00002 · Cited by 327
Injury of the renal microvascular endothelium alters barrier function after ischemia
Sutton, T. A., Mang, H. E., Campos, S. B., Sandoval, R. M., Yoder, M. C., & Molitoris, B. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00042.2003 · Cited by 325 · cited 1×
“Morphologically, disruption of the actin cytoskeleton and junctional complexes, similar to those previously described in tubule epithelial cells, now has been documented in endothelial cells in experimental AKI (126,127).”
Mitochondrial translocation of cofilin is an early step in apoptosis induction
Chua, B. T., Volbracht, C., Tan, K. O., Li, R., Yu, V. C., & Li, P. (2003) · Nature Cell Biology · doi:10.1038/ncb1070 · Cited by 316
Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells
Brodsky, S. V., Yamamoto, T., Tada, T., Kim, B., Chen, J., Kajiya, F., & Goligorsky, M. S. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00329.2001 · Cited by 303 · cited 2×
“Systemic or intrarenal administration of fully differentiated endothelial cells into postischemic rat kidneys resulted in a significant functional protection (130).”
BackgroundA role for extrarenal cells in the regeneration following acute renal failure
Gupta, S., Verfaillie, C., Chmielewski, D., Kim, Y., & Rosenberg, M. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00569.x · Cited by 293
Erythropoietin protects against ischaemic acute renal injury
Vesey, D. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg547 · Cited by 286 · cited 1×
“Similarly, erythropoietin, used extensively in humans for stimulating erythropoiesis, also has prominent antiapoptotic and antiinflammatory actions (179) and has been used successfully for functional amelioration of ischemic AKI in animals (65,77,180).”
BackgroundLack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
Thurman, J. M., Ljubanovic, D., Edelstein, C. L., Gilkeson, G. S., & Holers, V. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1517 · Cited by 283 · cited 1×
“animals (158) and humans (159) have implicated a predominant”
BackgroundBMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells1
Gould, S. E., Day, M., Jones, S. S., & Dorai, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00103.x · Cited by 254
Maladaptive Role of IL-6 in Ischemic Acute Renal Failure
Kielar, M. L., John, R., Bennett, M., Richardson, J. A., Shelton, J. M., Chen, L., Jeyarajah, D. R., Zhou, X. J., Zhou, H., Chiquett, B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003090757 · Cited by 253
Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury
Hamar, P., Song, E., Kökény, G., Chen, A., Ouyang, N., & Lieberman, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406421101 · Cited by 250 · cited 1×
“A leading contender for many years, the role of the Fas-FADD pathway in animal models, was reaffirmed recently by demonstration of upregulation of these proteins in apoptotic tubule cells after ischemia (58) and the functional protection that is afforded by small interfering RNA duplexes that target the Fas gene (61).”
BackgroundCCR2 Signaling Contributes to Ischemia-Reperfusion Injury in Kidney
Furuichi, K., Wada, T., Iwata, Y., Kitagawa, K., Kobayashi, K.-I., Hashimoto, H., Ishiwata, Y., Asano, M., Wang, H., Matsushima, K., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000089563.63641.a8 · Cited by 248 · cited 1×
“cognate receptor CCR2 on macrophages (143).”
Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils
de Vries, B., Köhl, J., Leclercq, W. K. G., Wolfs, T. G. A. M., van Bijnen, A. A. J. H. M., Heeringa, P., & Buurman, W. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3883 · Cited by 246
The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury
Sikorski, E. M., Hock, T., Hill-Kapturczak, N., & Agarwal, A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00297.2003 · Cited by 238
Kelly, K. J., Plotkin, Z., Vulgamott, S. L., & Dagher, P. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000040596.23073.01 · Cited by 230
Devarajan, P., Mishra, J., Supavekin, S., Patterson, L. T., & Steven Potter, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.09.012 · Cited by 229
Self-citationRegulation of tumor angiogenesis by thrombospondin-1
Ren, B., Yee, K. O., Lawler, J., & Khosravi-Far, R. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.11.002 · Cited by 225 · cited 1×
“(197), as another maximally induced gene early after ischemic”
BackgroundOxidative Stress Is Increased in Critically Ill Patients with Acute Renal Failure
Himmelfarb, J., McMonagle, E., Freedman, S., Klenzak, J., McMenamin, E., Le, P., Pupim, L. B., & Ikizler, T. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000138232.68452.3b · Cited by 221
American Society of Nephrology Renal Research Report
(2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030285 · Cited by 215
Inflammatory cytokines in acute renal failure
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09109.x · Cited by 208
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
Arumugam, T. V., Shiels, I. A., Strachan, A. J., Abbenante, G., Fairlie, D. P., & Taylor, S. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00737.x · Cited by 203
B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury
Burne-Taney, M. J., Ascon, D. B., Daniels, F., Racusen, L., Baldwin, W., & Rabb, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3210 · Cited by 197 · cited 1×
“cell deficiency confers renal protection (153).”
de Vries, B., Walter, S. J., Peutz-Kootstra, C. J., Wolfs, T. G. A. M., van Heurn, L. W. E., & Buurman, W. A. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63424-4 · Cited by 196
Intravital videomicroscopy of peritubular capillaries in renal ischemia
Yamamoto, T., Tada, T., Brodsky, S. V., Tanaka, H., Noiri, E., Kajiya, F., & Goligorsky, M. S. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00310.2001 · Cited by 196 · cited 1×
“prolonged vasoconstriction, and minimally invasive intravital microscopy has revealed sporadic cessation and even reversal of blood flow in peritubular capillaries during reperfusion (129,130).”
BackgroundCastaneda, M. P., Swiatecka-Urban, A., Mitsnefes, M. M., Feuerstein, D., Kaskel, F. J., Tellis, V., & Devarajan, P. (2003) · Transplantation · doi:10.1097/01.tp.0000069835.95442.9f · Cited by 195
Self-citationCantarovich, F., Rangoonwala, B., Lorenz, H., Verho, M., & Esnault, V. L. M. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00810-8 · Cited by 195
Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide
Neto, J. S., Nakao, A., Kimizuka, K., Romanosky, A. J., Stolz, D. B., Uchiyama, T., Nalesnik, M. A., Otterbein, L. E., & Murase, N. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00158.2004 · Cited by 193 · cited 1×
“Similarly, both carbon monoxide and carbon monoxide–releasing compounds are protective in animal models of ischemic AKI (19,20), likely through vasodilation and preservation of medullary blood flow, but have not been tested in humans.”
BackgroundDuffield, J. S., & Bonventre, J. V. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00629.x · Cited by 193
T cells as mediators in renal ischemia/reperfusion injury
Ysebaert, D. K., De Greef, K. E., De Beuf, A., Van Rompay, A. R., Vercauteren, S., Persy, V. P., & De brOE, M. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_4.x · Cited by 190
Increased C5a receptor expression in sepsis
Riedemann, N. C., Guo, R., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, V. J., Markiewski, M. M., Mastellos, D. C., Strey, C. W., Pierson, C. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15409 · Cited by 190 · cited 1×
“emia-reperfusion injury (166) and sepsis (167).”
Long-term effects of acute ischemia and reperfusion injury
Gueler, F., Gwinner, W., Schwarz, A., & Haller, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_11.x · Cited by 189
Tight junction biology and kidney dysfunction
Lee, D. B. N., Huang, E., & Ward, H. J. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00052.2005 · Cited by 189 · cited 1×
“culture, animal models, and human studies (48).”
Sung, F. L., Zhu, T. Y., Au-Yeung, K. K. W., Siow, Y. L., & Karmin, O. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid577.x · Cited by 181
Elevation of CXCR3-Binding Chemokines in Urine Indicates Acute Renal-Allograft Dysfunction
Hu, H., Aizenstein, B. D., Puchalski, A., Burmania, J. A., Hamawy, M. M., & Knechtle, S. J. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00354.x · Cited by 180 · cited 1×
“Elegant human studies demonstrated recently that the levels of the proinflammatory cytokines IL-6 and IL-8 in the plasma predict mortality in patients with AKI (139), and the levels of CXCR3binding chemokines in the urine predict AKI after kidney transplantation (140), attesting to the clinical significance of these m…”
BackgroundPatel, N. S. A., Chatterjee, P. K., Di Paola, R., Mazzon, E., Britti, D., De Sarro, A., Cuzzocrea, S., & Thiemermann, C. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078659 · Cited by 176
Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat
Forbes, J. M., Hewitson, T. D., Becker, G. J., & Jones, C. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00097.x · Cited by 175
A trial of thyroxine in acute renal failure
Acker, C. G., Singh, A. R., Flick, R. P., Bernardini, J., Greenberg, A., & Johnson, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00827.x · Cited by 174 · cited 1×
“However, although provision of exogenous adenine nucleotides or thyroxine (which stimulates mitochondrial ATP regeneration) can mitigate ischemic AKI in animal models, this approach has yielded disappointing results in human ARF (29,30).”
Resultde Vries, B., Matthijsen, R. A., Wolfs, T. G. A. M., van Bijnen, A. A. J. H. M., Heeringa, P., & Buurman, W. A. (2003) · Transplantation · doi:10.1097/01.tp.0000044455.05584.2a · Cited by 174
SINGBARTL, K., FORLOW, S. B., & LEY, K. (2001) · The FASEB Journal · doi:10.1096/fj.01-0199com · Cited by 170 · cited 1×
“However, subsequent studies have shown that it is platelet P-selectin, not endothelial P-selectin, that is the key component leading to AKI (135).”
BackgroundYokota, N., Burne-Taney, M., Racusen, L., & Rabb, H. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00432.2002 · Cited by 170 · cited 1×
“deleterious (Th1 phenotype) subtypes of T cells (150).”
BackgroundSpandou, E., Tsouchnikas, I., Karkavelas, G., Dounousi, E., Simeonidou, C., Guiba-Tziampiri, O., & Tsakiris, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi177 · Cited by 170 · cited 1×
“Similarly, erythropoietin, used extensively in humans for stimulating erythropoiesis, also has prominent antiapoptotic and antiinflammatory actions (179) and has been used successfully for functional amelioration of ischemic AKI in animals (65,77,180).”
BackgroundIschemic acute renal failure induces the expression of a wide range of nephrogenic proteins
Villanueva, S., Céspedes, C., & Vio, C. P. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00384.2005 · Cited by 168 · cited 1×
“Bone morphogenic protein-7 also is induced in postischemic tubules (75) and protects against ischemic AKI by decreasing the levels of MCP-1, IL-8, IL-6, and IL-1 in cultured proximal tubule cells (141).”
BackgroundLee, H. T., Gallos, G., Nasr, S. H., & Emala, C. W. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102474.68613.ae · Cited by 165
Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD59
Yamada, K., Miwa, T., Liu, J., Nangaku, M., & Song, W.-C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3869 · Cited by 164 · cited 1×
“(163,164), several recent observations have challenged this view”
BackgroundRole of apoptosis in hypoxic/ischemic damage in the kidney
Saikumar, P., & Venkatachalam, M. A. (2003) · Seminars in Nephrology · doi:10.1053/s0270-9295(03)00130-x · Cited by 161
Apoptotic pathways in ischemic acute renal failure
Kaushal, G. P., Basnakian, A. G., & Shah, S. V. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_6.x · Cited by 160
Doi, K., Suzuki, Y., Nakao, A., Fujita, T., & Noiri, E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00567.x · Cited by 159 · cited 1×
“A promising new advance in the field is the protective effect of edaravone, a potent scavenger of free radicals and inhibitor of lipid peroxidation when administered at the time of reperfusion in a rat model of ischemic AKI (34).”
BackgroundMøller-Kristensen, M., Wang, W., Ruseva, M. M., Thiel, S., Nielsen, S. M., Takahashi, K., Shi, L., Ezekowitz, A. B., Jensenius, J. C., & Gadjeva, M. G. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2005.01591.x · Cited by 157
OBERBAUER, R., ROHRMOSER, M., REGELE, H., MÜHLBACHER, F., & MAYER, G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1092006 · Cited by 154
Acute tubular necrosis is characterized by activation of the alternative pathway of complement
Thurman, J. M., Lucia, M. S., Ljubanović, D. G., & Holers, V. M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67109.x · Cited by 153 · cited 1×
“animals (158) and humans (159) have implicated a predominant”
Backgroundα-Melanocyte–stimulating Hormone Inhibits Lung Injury after Renal Ischemia/Reperfusion
Deng, J., Hu, X., Yuen, P. S. T., & Star, R. A. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-372oc · Cited by 151
Maeshima, A., Sakurai, H., & Nigam, S. K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040370 · Cited by 150
Cao, C. C., Ding, X. Q., Ou, Z.-L., Liu, C., Li, P., Wang, L., & Zhu, C. F. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00463.x · Cited by 149
Burne-Taney, M. J., Kofler, J., Yokota, N., Weisfeldt, M. L., Traystman, R. J., & Rabb, H. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2003 · Cited by 148
Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft.
Kwon, O., Nelson, W. J., Sibley, R. K., Huie, P., Scandling, J. D., Dafoe, D. C., Alfrey, E. J., & Myers, B. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci772 · Cited by 146
Protective Effect of Carbon Monoxide–Releasing Compounds in Ischemia-Induced Acute Renal Failure
Vera, T., Henegar, J. R., Drummond, H. A., Rimoldi, J. M., & Stec, D. E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090736 · Cited by 145 · cited 1×
“Similarly, both carbon monoxide and carbon monoxide–releasing compounds are protective in animal models of ischemic AKI (19,20), likely through vasodilation and preservation of medullary blood flow, but have not been tested in humans.”
BackgroundBasile, D. P., Donohoe, D. L., Roethe, K., & Mattson, D. L. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00169.2002 · Cited by 144
Cellular and molecular derangements in acute tubular necrosis
Devarajan, P. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000152620.59425.eb · Cited by 142 · cited 3×
“proteases and phospholipases and cytoskeletal degradation (28).”
BackgroundInfluentialSelf-citationIdentification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia
Thakar, C. V., Zahedi, K. A., Revelo, M. P., Wang, Z., Burnham, C. E., Barone, S., Bevans‐Fonti, S., Lentsch, A. B., Rabb, H., & Soleimani, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25461 · Cited by 142
APOPTOSIS IN ISCHEMIA/REPERFUSION INJURY OF HUMAN RENAL ALLOGRAFTS1
Burns, A. T., Davies, D. R., Mclaren, A. J., Cerundolo, L., Morris, P. J., & Fuggle, S. V. (1998) · Transplantation · doi:10.1097/00007890-199810150-00010 · Cited by 137
Postischemic Acute Renal Failure Is Reduced by Short-Term Statin Treatment in a Rat Model
Gueler, F., Rong, S., Park, J.-K., Fiebeler, A., Menne, J., Elger, M., Mueller, D. N., Hampich, F., Dechend, R., Kunter, U., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026609.45827.3d · Cited by 137
A1adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion
Lee, H. T., Xu, H., Nasr, S. H., Schnermann, J., & Emala, C. W. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00185.2003 · Cited by 134
Protective effect of T cell depletion in murine renal ischemia-reperfusion injury.
Yokota, N., Daniels, F. X., Crosson, J. T., & Rabb, H. (2002) · Transplantation · doi:10.1097/00007890-200209270-00005 · Cited by 132
Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury
Kelly, K. J., Sutton, T. A., Weathered, N., Ray, N., Caldwell, E. J., Plotkin, Z., & Dagher, P. C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00050.2004 · Cited by 132 · cited 1×
“(62), A1 adenosine receptor agonists (64), peroxisome prolifera-”
BackgroundSalahudeen, A. K., Huang, H. M., Joshi, M., Moore, N. A., & Jenkins, J. K. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00042.x · Cited by 130
Angiostatin and matrix metalloprotease expression following ischemic acute renal failure
Basile, D. P., Fredrich, K. M., Weihrauch, D., Hattan, N., & Chilian, W. M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00328.2003 · Cited by 129 · cited 1×
“Furthermore, ischemic injury leads to a marked upregulation of angiostatin, a widely known antiangiogenic factor that induces apoptosis of endothelial cells (131).”
BackgroundPoly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury
Zheng, J., Devalaraja-Narashimha, K. B., Singaravelu, K., & Padanilam, B. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00436.2003 · Cited by 129
Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes
Park, P., Haas, M., Cunningham, P. N., Bao, L., Alexander, J. J., & Quigg, R. J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2001 · Cited by 128
Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?
Vallet, B. (2003) · Critical Care · doi:10.1186/cc1864 · Cited by 128 · cited 1×
“endothelial cells have been demonstrated in humans with septic shock (128).”
BackgroundLate Consequences of Acute Ischemic Injury to a Solitary Kidney
Pagtalunan, M. E., Olson, J. L., Tilney, N. L., & Meyer, T. W. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102366 · Cited by 127
A catalogue of gene expression in the developing kidney
Schwab, K. R., Patterson, L. T., Aronow, B. J., Luckas, R., Liang, H.-C., & Potter, S. S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00276.x · Cited by 125
Gong, H., Wang, W., Kwon, T., Jonassen, T. E. N., Li, C., Ring, T., Frøkiær, J., & Nielsen, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00791.x · Cited by 119
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Dagher, P. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_7.x · Cited by 117 · cited 1×
“the mRNA (56) and protein (55) levels, and inhibition of p53 by”
BackgroundTransitioning to Therapy in Ischemic Acute Renal Failure
Molitoris, B. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000048852.53881.d9 · Cited by 113 · cited 1×
“Just like Heracles was summoned to vanquish the Hydra, a call to arms has been issued to the nephrology community to intervene in AKI (206,207).”
BackgroundGenome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function
Hauser, P., Schwarz, C. C., Mitterbauer, C., Regele, H. M., Mühlbacher, F., Mayer, G. J., Perco, P., Mayer, B., Meyer, T. W., & Oberbauer, R. W. (2003) · Laboratory Investigation · doi:10.1038/labinvest.3700037 · Cited by 111
Letavernier, E., Perez, J. D., Joye, E., Bellocq, A. G. A., Fouqueray, B., Haymann, J.-P., Heudes, D., Wahli, W., Desvergne, B., & Baud, L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090802 · Cited by 108 · cited 1×
“tor–activated receptor ligands (66), geranylgeranylacetone”
DNA Microarray Analysis of Complex Biologic Processes
Tamura, M. K., Hsiao, L., Yoshida, T., Randall, J., Chow, G. K., Sarang, S. S., Jensen, R. V., & Gullans, S. R. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251072 · Cited by 108
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure
Nemoto, T., Burne, M. J., Daniels, F. X., O'Donnell, M. P., Crosson, J. T., Berens, K. L., Issekutz, A. C., Kasiske, B. L., Keane, W. F., & Rabb, H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00054.x · Cited by 107
de Vries, B., Walter, S. J., von Bonsdorff, L., Wolfs, T. G. A. M., van Heurn, L. W. E., Parkkinen, J., & Buurman, W. A. (2004) · Transplantation · doi:10.1097/01.tp.0000115002.28575.e7 · Cited by 105
Gene Expression in the Normal Adult Human Kidney Assessed by Complementary DNA Microarray
Higgins, J., Wang, L., Kambham, N., Montgomery, K. D., Mason, V., Vogelmann, S. U., Lemley, K. V., Brown, P. O., Brooks, J. D., & van de Rijn, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-06-0432 · Cited by 103
Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?
Krause, D. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25540 · Cited by 101
Caspases as Drug Targets in Ischemic Organ Injury
Faubel, S. G., & Edelstein, C. L. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008054863754 · Cited by 101
Hoffmann, S. C., Kampen, R. L., Amur, S., Sharaf, M. A., Kleiner, D. E., Hunter, K., Swanson, S. J., Hale, D. A., Mannon, R. B., Blair, P. J., et al. (2002) · Transplantation · doi:10.1097/00007890-200210150-00003 · Cited by 98
Fayyazi, A., Scheel, O., Werfel, T., Schweyer, S., Oppermann, M., Götze, O., Radzun, H., & Zwirner, J. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00911.x · Cited by 98
Hoglen, N. C., Chen, L.-S., Fisher, C. D., Hirakawa, B. P., Groessl, T., & Contreras, P. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062034 · Cited by 97
Mizuno, S., & Nakamura, T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62498-4 · Cited by 97 · cited 1×
“tive and renotrophic in animal models of AKI, mediated by its proliferative, antiapoptotic, and anti-inflammatory actions (68).”
BackgroundCaspase Inhibition Improves Ischemia-Reperfusion Injury After Lung Transplantation
Quadri, S. M. S., Segall, L., de Perrot, M. E., Han, B., Edwards, V., Jones, N. L., Waddell, T. K., Liu, M., & Keshavjee, S. H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00701.x · Cited by 97
Bone Marrow Stem Cells Contribute to Healing of the Kidney
Poulsom, R., Alison, M. R., Cook, T. H., Jeffery, R. E., Ryan, E., Forbes, S. J., Hunt, T., Wyles, S. M., & Wright, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068162.02174.29 · Cited by 97
Damianovich, M., Ziv, I., Heyman, S. N., Rosen, S., Shina, A., Kidron, D., Aloya, T., Grimberg, H., Levin, G., Reshef, A., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1905-x · Cited by 93
The alternative pathway of complement in disease: opportunities for therapeutic targeting
Holers, V. M., & Thurman, J. M. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.012 · Cited by 93
Basile, D. P., Fredrich, K. M., Alausa, M., Vio, C. P., Liang, M., Rieder, M. R., Greene, A. S., & Cowley, A. W. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00329.2004 · Cited by 92 · cited 1×
“the onset of chronic fibrotic or sclerotic changes (203).”
BackgroundProtective Effect of HMG-CoA Reductase Inhibitor on Experimental Renal Ischemia-Reperfusion Injury
Yokota, N., O’Donnell, M. A., Daniels, F. X., Burne-Taney, M. J., Keane, W. F., Kasiske, B. L., & Rabb, H. (2002) · American Journal of Nephrology · doi:10.1159/000066301 · Cited by 91
Meldrum, K. K., Burnett, A. L. “., Meng, X., Misseri, R., SHAW, M. B. K., Gearhart, J. P., & Meldrum, D. R. (2003) · Circulation Research · doi:10.1161/01.res.0000057754.35180.99 · Cited by 91
Roelofs, J. J. T. H., Rouschop, K. M. A., Leemans, J. C., Claessen, N., Boer, A. M. T., Frederiks, W. M., LIJNEN, H. R., Weening, J. J., & Florquin, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010089 · Cited by 89
Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70
Suzuki, S., Maruyama, S., Sato, W., Morita, Y., Sato, F., Miki, Y., Kato, S., Katsuno, M., Sobue, G., Yuzawa, Y., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00326.x · Cited by 88 · cited 1×
“(an inducer of heat-shock proteins [HSP] [67]), and poly(ADP-”
BackgroundActin cytoskeleton in ischemic acute renal failure
Molitoris, B. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00818.x · Cited by 88 · cited 1×
“Alterations in the Apical Cytoskeleton Cellular ATP depletion leads to a rapid disruption of the apical actin cytoskeleton and redistribution of actin from the apical domain and microvilli into the cytoplasm (42).”
BackgroundStokman, G., Leemans, J. C., Claessen, N., Weening, J. J., & Florquin, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080678 · Cited by 87 · cited 1×
“Second, the majority of these bone marrow–derived cells were detected in the interstitial compartment and not in nephron segments, raising concerns for accentuation of renal fibrosis after AKI (118,119).”
BackgroundLeukocyte recruitment and acute renal failure
Singbartl, K., & Ley, K. F. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0498-8 · Cited by 87 · cited 2×
“Possible mechanisms include (1) adhesion of platelets to the endothelium, with subsequent leukocyte adhesion, and (2) adhesion of platelets to neutrophils, with consequent aggregate formation and trapping in narrow peritubular capillaries (132).”
BackgroundEffects of atorvastatin on inflammation and oxidative stress
Sugiyama, M., Ohashi, M., Takase, H., Sato, K., Ueda, R., & Dohi, Y. (2005) · Heart and Vessels · doi:10.1007/s00380-005-0833-9 · Cited by 86
The Juxtaglomerular Apparatus: From Anatomical Peculiarity to Physiological Relevance
Schnermann, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000069221.69551.30 · Cited by 86
HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells
Ruchalski, K. L., Mao, H., Singh, S. K., Wang, Y., Mosser, D. D., Fang-hong, L., Schwartz, J. H., & Borkan, S. C. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00049.2003 · Cited by 85 · cited 1×
“HSP promote cell survival by inhibiting apoptosis (95), Figure 3.”
BackgroundKwon, O., Corrigan, G., Myers, B. D., Sibley, R. K., Scandling, J. D., Dafoe, D. C., Alfrey, E. J., & Nelson, W. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003963.x · Cited by 83
Newly Developed Techniques to Study and Diagnose Acute Renal Failure
Dagher, P. C., Herget‐Rosenthal, S., Ruehm, S. G., Jo, S.-K., Star, R. A., Agarwal, R., & Molitoris, B. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079790.91292.4a · Cited by 83 · cited 1×
“Sophisticated imaging techniques have documented these changes in regional renal blood flow in animals and validated them in human AKI (16).”
BackgroundGhrelin Improves Renal Function in Mice with Ischemic Acute Renal Failure
Takeda, R., Nishimatsu, H., Suzuki, E., Satonaka, H., Nagata, D., Oba, S., Sata, M., Takahashi, M., Yamamoto, Y., Terauchi, Y., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080626 · Cited by 83 · cited 1×
“Interest in IGF-1 therapy has been rekindled by the recent discovery of ghrelin, a naturally occurring growth hormone secretagogue that markedly increases serum IGF-1 levels and protects the kidney from ischemic injury by improving endothelial function and vasodilation in animals (78).”
BackgroundCheng, C., Rifai, A., Ka, S., Shui, H., Lin, Y., Lee, W., & Chen, A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00740.x · Cited by 82
Hladunewich, M., Corrigan, G., Derby, G. C., Ramaswamy, D., Kambham, N., Scandling, J. D., & Myers, B. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00100.x · Cited by 81
Atorvastatin Improves the Course of Ischemic Acute Renal Failure in Aging Rats
Sabbatini, M., Pisani, A., Uccello, F., Serio, V., Serù, R., Paternò, R., Cianciaruso, B., Fuíano, G., & Andreucci, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000119573.01290.ae · Cited by 79
Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells
Kwon, O., Phillips, C. L., & Molitoris, B. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00294.2001 · Cited by 75 · cited 1×
“Morphologically, disruption of the actin cytoskeleton and junctional complexes, similar to those previously described in tubule epithelial cells, now has been documented in endothelial cells in experimental AKI (126,127).”
ADF/cofilin mediates actin cytoskeletal alterations in LLC-PK cells during ATP depletion
Ashworth, S. L., Southgate, E. L., Sandoval, R. M., Meberg, P. J., Bamburg, J. R., & Molitoris, B. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00210.2002 · Cited by 75
Heat-shock protein 70: molecular supertool?
Aufricht, C. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1812-6 · Cited by 74
Targeting apoptosis in acute tubular injury
Ortíz, A., Justo, P., Sanz, A. B., Lorz, C., & Egido, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00515-x · Cited by 74
Prevention and nondialytic treatment of acute renal failure
Lameire, N. H., Vriese, A. S. D., & Vanholder, R. C. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200312000-00004 · Cited by 73 · cited 1×
“All things considered, these macrohemodynamic abnormalities cannot account fully for the profound loss of renal function, and several human trials of vasodilators such as dopamine have failed to demonstrate improvement in GFR in established ARF despite augmentation of total renal blood flow (21).”
BackgroundThe Effects of Atorvastatin (10 mg) on Systemic Inflammation in Heart Failure
Mozaffarian, D., Minami, E., Letterer, R. A., Lawler, R. L., McDonald, G. B., & Levy, W. C. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.092 · Cited by 73
Yang, B., Jain, S., Pawluczyk, I. Z. A., Imtiaz, S., Bowley, L., Ashra, S. Y., & Nicholson, M. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00662.x · Cited by 70
Yoshino, J., Monkawa, T., Tsuji, M., Hayashi, M., & Saruta, T. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000101180.96787.02 · Cited by 70 · cited 1×
“hibitory factor (103), transcription factor Ets-1 (104), and Wnt-4 (105).”
BackgroundBid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice
Wei, Q., Yin, X., Wang, M.-H., & Dong, Z. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00184.2005 · Cited by 69
HEAT SHOCK PROTEINS, ANTI-HEAT SHOCK PROTEIN REACTIVITY AND ALLOGRAFT REJECTION
Pockley, A. G. (2001) · Transplantation · doi:10.1097/00007890-200106150-00001 · Cited by 67 · cited 1×
“However, that this also may activate undesirable cellular processes such as increased immunogenicity (99) serves to caution us against leaping from the frying pan into the fire when contemplating HSP therapies.”
BackgroundIschemic injury induces ADF relocalization to the apical domain of rat proximal tubule cells
Ashworth, S. L., Sandoval, R. M., Hosford, M., Bamburg, J. R., & Molitoris, B. A. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.5.f886 · Cited by 66
Thyroid Hormone in the Treatment of Post-transplant Acute Tubular Necrosis (ATN)
Acker, C. G., Flick, R. P., Shapiro, R., Scantlebury, V. P., Jordan, M. L., Vivas, C., Greenberg, A., & Johnson, J. P. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.020110.x · Cited by 63 · cited 1×
“However, although provision of exogenous adenine nucleotides or thyroxine (which stimulates mitochondrial ATP regeneration) can mitigate ischemic AKI in animal models, this approach has yielded disappointing results in human ARF (29,30).”
ResultBianchi, P., Séguélas, M., Parini, A., & Cambon, C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000058909.00567.5c · Cited by 63
Role of polymeric Tamm-Horsfall protein in cast formation: Oligosaccharide and tubular fluid ions
Wangsiripaisan, A., Gengaro, P. E., Edelstein, C. L., & Schrier, R. W. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059003932.x · Cited by 61 · cited 1×
“typically is encountered in the distal tubule in AKI (22).”
BackgroundFiaschi-Taesch, N. M., Santos, S., Reddy, V., Van Why, S. K., Philbrick, W. F., Ortega, A., Esbrit, P., Orloff, J. J., & Garcia-Ocan[Combining Tilde]a, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102470.12285.c6 · Cited by 61 · cited 1×
“Encouraging, selective overexpression of the HGF transgene in the proximal tubule via the -glutamyl transpeptidase-1 promoter bestowed remarkable functional protection from ischemic AKI, with enhanced tubule cell proliferation and decreased apoptosis (107).”
BackgroundAcute renal failure: From renal physiology to the renal transcriptome
Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09110.x · Cited by 60 · cited 1×
“The reader is referred to recent publications that address the mechanisms that underlie other causes of intrinsic AKI, such as sepsis (8) and nephrotoxins (9).”
BackgroundFirst human studies with a high-molecular-weight iron chelator
Dragsten, P. R., Hallaway, P. E., Hanson, G. J., Berger, A. E., Bernard, B. K., & Hedlund, B. E. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(00)70021-7 · Cited by 60
Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure
Devalaraja-Narashimha, K. B., Singaravelu, K., & Padanilam, B. J. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.022 · Cited by 59
Chatterjee, P. K., Chatterjee, B. E., Pedersen, H. P., Sivarajah, A., McDonald, M. C., Mota‐Filipe, H., Brown, P. A., Stewart, K. N., Cuzzocrea, S., Threadgill, M. D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00415.x · Cited by 56 · cited 1×
“ribose) polymerase inhibitors (91) all have provided encourag-”
BackgroundRio, M. D., Imam, A. A., DeLeon, M., Gomez, G., Mishra, J., Ma, Q., Parikh, S. M., & Devarajan, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000104840.04124.5c · Cited by 56 · cited 1×
“A leading contender for many years, the role of the Fas-FADD pathway in animal models, was reaffirmed recently by demonstration of upregulation of these proteins in apoptotic tubule cells after ischemia (58) and the functional protection that is afforded by small interfering RNA duplexes that target the Fas gene (61).”
BackgroundSelf-citationSchwarz, C. C., Hauser, P., Steininger, R., Regele, H. M., Heinze, G., Mayer, G. J., & Oberbauer, R. W. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000021174.66841.4c · Cited by 55
Molina, A., Cantera, M., Escribese, M. M., García‐Bermejo, L., Sancho, D., de Lema, G. P., Liaño, F., Cabañas, C., Sánchez‐Madrid, F., & Mampaso, F. M. (2004) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070528 · Cited by 54
Need to Intervene in Established Acute Renal Failure
Schrier, R. W. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141324.49873.11 · Cited by 54 · cited 1×
“Just like Heracles was summoned to vanquish the Hydra, a call to arms has been issued to the nephrology community to intervene in AKI (206,207).”
BackgroundCytoprotective Effects of Heme Oxygenase in Acute Renal Failure
Akagi, R., Takahashi, T., & Sassa, S. (2005) · Contributions to Nephrology · doi:10.1159/000086044 · Cited by 53
Transplantation of the Intestine: Is it Truly Different?
Newell, K. A. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.30101.x · Cited by 50
Peripheral CD4 T-Cell Depletion Is Not Sufficient to Prevent Ischemic Acute Renal Failure
Faubel, S. G., Ljubanović, D. G., Poole, B., Dursun, B., He, Z., Cushing, S., Somerset, H., Gill, R. G., & Edelstein, C. L. (2005) · Transplantation · doi:10.1097/01.tp.0000173396.07368.55 · Cited by 50
Dissociation of spectrin-ankyrin complex as a basis for loss of Na-K-ATPase polarity after ischemia
Woroniecki, R. P., Ferdinand, J. R., Morrow, J. S., & Devarajan, P. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00100.2002 · Cited by 50
Self-citationQuigg, R. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3319 · Cited by 48
Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure
Jerkić, M., Miloradović, Z., Jovović, D., Mihailovic‐Stanojevic, N., Elena, J. V. R., Nastić-Mirić, D., Grujić-Adanja, G., Rodríguez‐Barbero, A., Markovic‐Lipkovski, J., Vojvodic, S. B., et al. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg521 · Cited by 48 · cited 1×
“Endothelin receptor antagonists ameliorate ischemic AKI in animals (18), but human data are lacking.”
BackgroundFernández, M. A., Medina, A., Santos, F., Carbajo, E., Rodríguez, J., Álvarez, J., & COBO, A. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1291900 · Cited by 48
Contribution of Angiotensin II to Late Renal Injury after Acute Ischemia
Pagtalunan, M. E., Olson, J. L., & Meyer, T. W. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171278 · Cited by 46
Stem cells and progenitor cells in renal disease
Haller, H. G., de Groot, K., Bahlmann, F. H., Elger, M., & Fliser, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00622.x · Cited by 45
Sahlstedt, L., von Bonsdorff, L., Ebeling, F. T., Ruutu, T., & Parkkinen, J. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03836.x · Cited by 44 · cited 1×
“Apotransferrin has been used successfully for the reduction of redox-active iron in patients who have undergone hematologic stem cell transplantation without any adverse effects (37).”
BackgroundExpression and Function of Ets-1 during Experimental Acute Renal Failure in Rats
Tanaka, H., Terada, Y., Kobayashi, T., Okado, T., Inoshita, S., Kuwahara, M., Seth, A. K., Sato, Y., & Sasaki, S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145459.54236.d3 · Cited by 43
de Vries, B., Walter, S. J., Wolfs, T. G. A. M., Hochepied, T., Räbinä, J., Heeringa, P., Parkkinen, J., Libert, C., & Buurman, W. A. (2004) · Transplantation · doi:10.1097/01.tp.0000138096.14126.ca · Cited by 43
Heat Shock (Stress Response) Proteins and Renal Ischemia/Reperfusion Injury
Kelly, K. J. (2005) · KARGER eBooks · doi:10.1159/000086054 · Cited by 42
Riordan, M., Sreedharan, R., Wang, S., Thulin, G., Mann, A. S., Stankewich, M. C., Why, S. K. V., Kashgarian, M. J., & Siegel, N. J. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00438.2004 · Cited by 42 · cited 1×
“In cultured tubule cells, inhibition of the HSP response by gene-silencing techniques produced profound impairment of cellular integrity and Na,K-ATPase polarity (97), and overexpression of HSP-70 mitigated the loss of Na,K-ATPase polarity after ATP depletion (98).”
BackgroundTowards a Definition and Classification of Acute Kidney Injury
Warnock, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090934 · Cited by 42 · cited 1×
“An inherent shortcoming of this term is the continued reliance on serum creatinine measurements, and the definition of AKI undoubtedly will undergo enhancements as novel early biomarkers for the identification of ARF before the rise in serum creatinine come to light (7).”
BackgroundBid activation in kidney cells following ATP depletion in vitro and ischemia in vivo
Wei, Q., Alam, M. M., Wang, M.-H., Yu, F. X., & Dong, Z. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00093.2003 · Cited by 40 · cited 1×
“However, there is growing evidence implicating an imbalance between the proapoptotic (Bax and Bid) and antiapoptotic (Bcl-2 and Bcl-xL) members of the Bcl-2 family in both animal (63,79) and human (10,82–84) situations.”
BackgroundPathophysiological Contributions of Fucosyltransferases in Renal Ischemia Reperfusion Injury
Burne, M. J., & Rabb, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2648 · Cited by 38
Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients
Shilliday, I. R., & Sherif, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003421.pub4 · Cited by 38
Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney
Rabb, H. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00102.2005 · Cited by 38 · cited 1×
“Fourth, the mode of protection by exogenously administered MSC may be related not to transdifferentiation processes but rather to powerful anti-inflammatory and antiapoptotic mechanisms that are being uncovered (117,124,125).”
BackgroundWhispers and shouts in the pathogenesis of acute renal ischaemia
Goligorsky, M. S. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh182 · Cited by 38 · cited 1×
“Collectively, these findings provide a rationale for the use of proangiogenic agents that can increase the pool or mobilization of endothelial progenitor cells, such as erythropoietin, bone morphogenic protein, vascular endothelial growth factor, and statins (17).”
BackgroundInduction of Zf9 in the kidney following early ischemia/reperfusion
Tarabishi, R., Zahedi, K. A., Mishra, J., Ma, Q., Kelly, C. N., Tehrani, K., & Devarajan, P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00563.x · Cited by 35 · cited 1×
“mitigated the apoptotic response to ATP depletion in vitro (196).”
BackgroundSelf-citationThe Effects of Statins on Endothelium, Inflammation and Cardioprotection
Elrod, J. W., & Lefer, D. J. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.4.908656 · Cited by 34
Chatterjee, P. K., Todorović, Z., Sivarajah, A., Mota‐Filipe, H., Brown, P. A., Stewart, K. N., Cuzzocrea, S., & Thiemermann, C. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.025 · Cited by 34
Langer, R., Wang, M., Stepkowski, S. M., Hancock, W. W., Han, R., Li, P., Feng, L., Kirken, R. A., Berens, K. L., Dupré, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000142425.23036.ac · Cited by 34 · cited 1×
“Bimosiamose, a novel pan-selectin inhibitor, protected from ischemic AKI in a kidney transplant model by reducing infiltration of macrophages and T cells and inhibiting intragraft expression of chemokines and cytokines (172).”
BackgroundLi, G. C., & Mivechi, N. F. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58259-2_3 · Cited by 31
Transcriptome analysis and kidney research: Toward systems biology
Liang, M., Cowley, A. W., Hessner, M. J., Lazar, J., Basile, D. P., & Pietrusz, J. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00315.x · Cited by 30
Renal ischemia induces tropomyosin dissociation-destabilizing microvilli microfilaments
Ashworth, S. L., Wean, S. E., Campos, S. B., Temm, C. J., Southgate, E. L., Vrhovski, B., Gunning, P. W., Weinberger, R. P., & Molitoris, B. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00168.2003 · Cited by 29 · cited 1×
“the actin-stabilizing proteins tropomyosin and ezrin (45), allow-”
Background
Cited by
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Hot weather and heat extremes: health risks
Ebi, K. L., Capon, A., Berry, P., Broderick, C., de Dear, R., Havenith, G., Honda, Y., Kovats, R. S., Ma, W., Malik, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01208-3 · Cited by 2,172
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kashani, K., Al-Khafaji, A., Ardiles, T., Artigas, A., Bagshaw, S. M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C. M., Chawla, L. S., et al. (2013) · Critical Care · doi:10.1186/cc12503 · Cited by 1,362
“It is notable therefore that IGFBP7 and TIMP-2 are both involved with the phenomenon of G1 cell cycle arrest during the very early phases of cell injury (Figure 5) [21-24].”
Background
Metadata
- Authors
- Devarajan, P.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Devarajan, Prasad
- ORCID
- Devarajan, Prasad
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-06
- Volume
- 17
- Issue
- 6
- Pages
- 1503-1520
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164965999
- Cited by
- 1,026
- References
- 209
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 45 · 2023: 38 · 2022: 39 · 2021: 43 · 2020: 56 · 2019: 53 · 2018: 56 · 2017: 55 · 2016: 82 · 2015: 87 · 2014: 74 · 2013: 64 · 2012: 62
- FWCI
- 26.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK 52612, R21DK070163, R01-DK53289, P50DK052612, R01DK053289)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Keywords
- acute kidney injury, ischemic acute kidney injury, acute tubular necrosis, renal tubular epithelial cells, tubular epithelial cell proliferation, renal tubular regeneration, renal hypoxia, renal ischemia-reperfusion injury, AKI pathogenesis, kidney injury biomarkers, AKI definitions, serum creatinine limitations
- MeSH terms
- Acute Disease, Adenosine Triphosphate, Animals, Calcium, Humans, Ischemia, Kidney, Kidney Tubules, Models, Biological, Regional Blood Flow, Reactive Oxygen Species, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.